Insider trades
Stock that executives, directors and 10% owners bought and sold on the open market, from the Form 4s they file with the SEC within two business days. Grants, option exercises and shares sold to cover taxes are left out.
- $697M bought by 128 insiders at 87 companies
- $536M sold by 83 insiders outside a trading plan
- $1B sold by 343 insiders under 10b5-1 plans
- 10 companies where two or more insiders bought (30 days)
Biggest buys
Past month · by insider, all their filings added up
-
LENLennar CorporationBerkshire Hathaway Inc.10% owner · +1 joint filer$247M
-
KODKodiak Sciences IncBaker Bros. Advisors LPDirector · +5 joint filers$157M
-
UUUUniversal Safety Products, Inc.Milton C Ault IIIDirector$92.4M
-
GPIGroup 1 Automotive, Inc.Conifer Management, L.L.C.10% owner$66.3M
-
CRBGCorebridge Financial Inc.Life Insurance Co Nippon10% owner$62M
-
GMEGameStop CorporationRyan CohenCEO$17.1M
-
AVRAnteris Technologies Global Corp.L1 Capital Pty Ltd10% owner$9.7M
-
BORRBorr Drilling LimitedTor Olav TroimDirector$6.2M
-
PAMPampa Energia S.A.Damian Miguel MindlinVicepresident$5.6M
-
GPUSHyperscale Data, Inc.Milton C Ault IIIChair · +1 joint filer$5.1M
Biggest sales
Past month · by insider, all their filings added up · planned sales marked
-
THTarget Hospitality Corp.TDR Capital II Investments LP10% owner · +9 joint filers$202M
-
ESTCElastic N.V.Steven SchuurmanDirector$135M
-
NBISNebius Group N.V.Ophir NaveCOO$118M
-
CBRSCerebras Systems Inc.Dhiraj MallickCOO$80.8M
-
CRWDCrowdStrike Holdings, Inc.Michael SentonasPresident$64.2M
-
AAPLApple Inc ComTimothy D CookChair$63.8M
-
MPWRMonolithic Power Systems, Inc.Michael HsingCEO$40.3M
-
ACTEnact Holdings, Inc.Genworth Holdings, Inc.10% owner$37.1M
-
WDAYWorkday, Inc.David A Duffield10% owner$37.1M
-
MEDPMedpace Holdings, Inc.August J. TroendleCEO$30.3M
Cluster buying
Companies where two or more insiders bought on the open market in the last 30 days · most buyers first
-
Reuben S Leibowitz Director, Larry C Glasscock Director, Daniel C. Smith Director, Gary M Rodkin Director, +7 more
-
Daniel L Florness Director, Srilata Zaheer Director, Charles T Lauber Director, Trangsrud Teresa J Rasmussen Director, +3 more
-
Matthew G De Soto Director, Albert J. Evans Director, Kimberly J Brumbaugh Director, Theodore W Mowery Director, +1 more
-
Joseph D Sarafa Director, Brian J Roney CEO, James Grant Smith Director, Harold J Meloche CFO
-
Michael Jordan Osborn CEO, Gregory William Voorhies Director, James W Bernau President, Chris Riccardi Director
-
J Tutt Barrett Director, David E Housel Director, William F Ham Jr. Director, Shannon O'Donnell Senior Vice President
-
Cesar Nivaldo Gon CEO, Fernando Matt Borges Martins Director, Neto Bruno Guicardi Pres. of N. Am. /Europe Ops
-
Joshua Horowitz Director, John Taylor Maloney Fitzgerald CEO, Kent A Hansen CFO
-
Ryan Cohen CEO, Nat Turner Director
-
Milton C Ault III Chair, William B. Horne CEO
All insider trades
Newest filings first · one row per filing · every open-market buy and sale
-
Eugene Scott Crist DirectorARBEArbe Robotics Ltd.Buy$30K 50,000 shares at $0.6100 +5.2% to stakeTraded Sep 28 Filed Oct 6
-
Anthony Mathew Eisen DirectorXYZBlock, Inc.Planned sale$1.4M 18,000 shares at $75.51 1.4% of stakeTraded Oct 2–6 Filed Oct 6
-
Fred Joseph Deutsch DirectorFCCOFirst Community CorporationSale$15 0 shares at $32.57 <0.1% of stakeTraded Oct 5 Filed Oct 6
-
Barry J. Simon DirectorIBRXImmunityBio, Inc.Planned sale$269K 25,000 shares at $10.75 0.9% of stakeTraded Oct 5 Filed Oct 6
-
Cheryl Cohen DirectorIBRXImmunityBio, Inc.Planned sale$851K 81,056 shares at $10.50 45% of stakeTraded Oct 2 Filed Oct 6
-
Peter Greenleaf DirectorPTHSPelthos Therapeutics Inc.Planned sale$17K 797 shares at $21.17 3.3% of stakeTraded Oct 2 Filed Oct 6
-
Ezra M Friedberg DirectorPTHSPelthos Therapeutics Inc.Planned sale$12K 558 shares at $20.72 0.7% of stakeTraded Oct 2 Filed Oct 6
-
Matthew Pauls DirectorPTHSPelthos Therapeutics Inc.Planned sale$17K 786 shares at $21.00 5.5% of stakeTraded Oct 2 Filed Oct 6
-
Yvonne Wassenaar DirectorRBRKRubrik, Inc.Planned sale$86K 721 shares at $119.00 19% of stakeTraded Oct 5 Filed Oct 6
-
Raanan Zilberman DirectorVSHVishay Intertechnology, Inc.Planned sale$594K 16,575 shares at $35.82 34% of stakeTraded Oct 2 Filed Oct 6
-
Corinna Lathan DirectorPTCPTC Inc.Planned sale$343K 1,750 shares at $195.75 21% of stakeTraded Oct 5 Filed Oct 6
-
Eugene A Scherbakov DirectorIPGPIPG Photonics CorporationPlanned sale$260K 3,048 shares at $85.30 6.3% of stakeTraded Oct 2 Filed Oct 6
-
Douglas A Alexander DirectorAMKRAmkor Technology, Inc.Planned sale$275K 5,000 shares at $55.00 15% of stakeTraded Oct 2 Filed Oct 6
-
William A Newlands ChairHRLHormel Foods CorporationBuy$201K 10,000 shares at $20.10 +15% to stakeTraded Oct 5 Filed Oct 6
-
Steven Schuurman DirectorESTCElastic N.V.Sale$135M 1,500,000 shares at $90.13 25% of stakeTraded Oct 5 Filed Oct 6
-
Carrie Palin DirectorNTAPNetApp, Inc.Sale$1.1M 5,000 shares at $216.43 43% of stakeTraded Oct 2 Filed Oct 6
-
Michael J Kasbar ChairWKCWorld Kinect CorporationPlanned sale$357K 10,000 shares at $35.67 1% of stakeTraded Oct 2 Filed Oct 6
-
Amy Guggenheim Shenkan DirectorRNGRingCentral, Inc.Planned sale$100K 1,264 shares at $78.89 4.3% of stakeTraded Oct 2 Filed Oct 6
-
Amar K. Goel ChairPUBMPubMatic, Inc.Planned sale$201K 10,795 shares at $18.66 23% of stakeTraded Oct 5 Filed Oct 6
-
Gokul Rajaram DirectorPINSPinterest, Inc.Planned sale$21K 1,050 shares at $20.00 2.8% of stakeTraded Oct 5 Filed Oct 6
-
Brian S Posner DirectorDYNDyne Therapeutics, Inc.Buy$40K 2,500 shares at $16.00 +10% to stakeTraded Oct 2 Filed Oct 6
-
Stanley Tang DirectorDASHDoorDash, Inc.Planned sale$4.3M 23,125 shares at $186.19 69% of stakeTraded Oct 2 Filed Oct 6
-
Keith R Larson DirectorNWPXNWPX Infrastructure, Inc.Planned sale$27K 250 shares at $106.48 1.7% of stakeTraded Oct 5 Filed Oct 6
-
Debra Zumwalt DirectorHURNHuron Consulting Group Inc.Planned sale$14K 82 shares at $167.75 0.3% of stakeTraded Oct 2 Filed Oct 6
-
Tor Olav Troim DirectorBORRBorr Drilling LimitedBuy$6.2M 1,500,000 shares at $4.13 +4.9% to stakeTraded Oct 5 Filed Oct 6
-
Charles Kane DirectorSYMSymbotic Inc.Planned sale$86K 2,000 shares at $43.17 2.2% of stakeTraded Oct 1 Filed Oct 5
-
Gerald Held DirectorNTAPNetApp, Inc.Sale$1.2M 5,757 shares at $212.00 36% of stakeTraded Oct 1 Filed Oct 5
-
Lauren Elaina Friedman Stat DirectorPLTRPalantir Technologies Inc.Planned sale$254K 1,337 shares at $189.95 2.5% of stakeTraded Oct 1 Filed Oct 5
-
Sameer K Gandhi DirectorCRWDCrowdStrike Holdings, Inc.Planned sale$14.3M 54,000 shares at $265.22 1.9% of stakeTraded Oct 1 Filed Oct 5
-
Mark B Templeton DirectorANETArista Networks, Inc.Planned sale$1M 5,000 shares at $204.37 9.4% of stakeTraded Oct 1 Filed Oct 5
-
Timothy D Cook ChairAAPLApple Inc ComPlanned sale$63.8M 191,753 shares at $332.96 5.5% of stakeTraded Oct 2 Filed Oct 5
-
Daniel Masters DirectorCSHRCoinShares PLCPlanned sale$492K 100,000 shares at $4.92 0.5% of stakeTraded Oct 1–5 Filed Oct 5
-
Neil D Hunt DirectorROKURoku, Inc.Planned sale$302K 2,000 shares at $151.09 17% of stakeTraded Oct 1 Filed Oct 5
-
Melissa B Epperly DirectorROIVRoivant Sciences Ltd.Planned sale$641K 17,750 shares at $36.10 54% of stakeTraded Oct 1 Filed Oct 5
-
Gregory William Voorhies DirectorWVVIWillamette Valley Vineyards, Inc.Buy$12K 6,000 shares at $1.92 +25% to stakeTraded Oct 2–5 Filed Oct 5
-
Michael E Maroone DirectorCVNACarvana Co.Buy$1.5M 25,000 shares at $61.80 +3.5% to stakeTraded Jul 31 Filed Oct 5
-
Jeffrey W Dunn DirectorSIBNSI-BONE, Inc.Planned sale$369K 20,000 shares at $18.47 56% of stakeTraded Oct 1 Filed Oct 5
-
Christopher M Starr DirectorMNPRMonopar Therapeutics Inc.Planned sale$659K 8,400 shares at $78.50 62% of stakeTraded Oct 1 Filed Oct 5
-
Marc L Andreessen DirectorCOINCoinbase Global, Inc.Planned sale$3.9M 20,514 shares at $190.12 1.8% of stakeTraded Oct 1–2 Filed Oct 5
-
Paul Seid DirectorINLXIntellinetics, Inc.Buy$834 162 shares at $5.15 +0.1% to stakeTraded Oct 1 Filed Oct 5
-
John Philip Coghlan DirectorLIFLife360, Inc.Planned sale$161K 4,000 shares at $40.37 24% of stakeTraded Oct 1 Filed Oct 5
-
Donald Allen Williams DirectorPALIPalisade Bio, Inc.Buy$29K 20,000 shares at $1.44 +1.3% to stakeTraded Oct 1–2 Filed Oct 5
-
Ori Winitzer DirectorLCIDLcidPlanned sale$4,120 1,000 shares at $4.12 1.5% of stakeTraded Oct 1 Filed Oct 5
-
Vincentelli Alberto Sangiovanni DirectorCDNSCadence Design Systems, Inc.Planned sale$438K 1,250 shares at $350.07 3.1% of stakeTraded Oct 1 Filed Oct 5
-
Frederic Simon DirectorFROGJFrog Ltd.Planned sale$11.7M 120,000 shares at $97.24 4.2% of stakeTraded Oct 1 Filed Oct 5
-
J. Scott Garland DirectorELVNEnliven Therapeutics, Inc.Sale$607K 13,000 shares at $46.67 100% of stakeTraded Oct 1 Filed Oct 5
-
Noel Joseph Spiegel DirectorAEOAmerican Eagle Outfitters, Inc.Sale$64K 3,617 shares at $17.68 100% of stakeTraded Oct 2 Filed Oct 5
-
Josh Silverman ChairETSYEtsyPlanned sale$151K 2,090 shares at $72.45 0.8% of stakeTraded Oct 1 Filed Oct 5
-
Alejandro Gustavo Elsztain DirectorLNDBrasilagro Cia Brasileira De Propriedades AgricolasBuy$200K 56,750 shares at $3.52 +8.5% to stakeTraded Sep 30–Oct 5 Filed Oct 5
-
Stephan D Memmen DirectorAIRGAirgain, Inc.Buy$6,825 1,500 shares at $4.55 +2.7% to stakeTraded Oct 2 Filed Oct 5
About this data
- Officers, directors and anyone owning more than 10% of a company must report a trade in its stock on a Form 4 within two business days. We read each filing from SEC EDGAR and link to it on every row.
- Only open-market purchases and sales of common stock count here. Stock grants, option exercises, gifts and shares withheld or sold to pay taxes on vesting awards are not decisions to buy or sell, so they are left out.
- A planned sale was made under a Rule 10b5-1 trading plan, which the insider set up months in advance. Many executives sell this way on a schedule, so a planned sale says less than one made on the day.
- Values are shares times the price reported. When a filing amends an earlier one, the amended trades replace the originals. Related owners (a fund and its manager) who report the same trade separately are shown once.
- We cover the 4,792 US companies on our earnings calendar, with a year of history. The superinvestor notes count the featured 13F managers who added or cut the stock in their latest quarter.